Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole

Journal of Nuclear Medicine

Volumn 45, Issue 5, 2004, Pages 730-738

  Kubo, Shigeto ^a   Tadamura, Eiji ^a   Toyoda, Hiroshi ^a   Mamede, Marcelo ^a   Yamamuro, Masaki ^a   Magata, Yasuhiro ^b   Mukai, Takahiro ^a   Kitano, Haruhiro ^a   Tamaki, Nagara ^c   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosine triphosphate; Caffeine; Dipyridamole; Myocardial blood flow; PET

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAFFEINE; CAFFEROP; DIPYRIDAMOLE; UNCLASSIFIED DRUG; WATER O 15; DIAGNOSTIC AGENT; OXYGEN; VASODILATOR AGENT; WATER;

ACUTE DISEASE; ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG BLOOD LEVEL; DRUG MECHANISM; DYSPNEA; EPIGASTRIC DISCOMFORT; FLUSHING; HEADACHE; HEART BLOCK; HEART PALPITATION; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIDE EFFECT; STOMACH PAIN; THORAX PAIN; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; HEART; HYPEREMIA; INTRAVENOUS DRUG ADMINISTRATION; SCINTISCANNING;

ADENOSINE TRIPHOSPHATE; ADULT; CAFFEINE; CORONARY CIRCULATION; DIPYRIDAMOLE; HEART; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; MALE; OXYGEN RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATOR AGENTS; WATER;

EID: 2642544217     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331:222-227.
2. Rosen SD, Uren NG, Kaski JC, et al. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation. 1994;90:50-60.
3. Ogilby JD, Kegel JG, Heo J, Iskandrian AE. Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia. J Am Coll Cardiol. 1998;31:75-82.
4. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69-77.
5. Miyagawa M, Kumano S, Sekiya M, et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnostic of coronary artery disease. J Am Coll Cardiol. 1995;26:1196-1201.
6. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med. 1997;38:577-581.
7. Smits P, Lenders JW, Thien T. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther. 1990;48:410-418.
8. Bottcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med. 1995;36:2016-2021.
9. Jacobson AF, Cerqueira MD, Raisys V, Shattuc S. Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine. Eur J Nucl Med. 1994;21:23-26.
10. Vials AJ, Burnstock G. The effect of suramin on vasodilator responses to ATP and 2-methylthio-ATP in the Sprague-Dawley rat coronary vasculature. Eur J Pharmacol. 1994;251:299-302.
11. Korchazhkina O, Wright G, Exley C. Intravascular ATP and coronary vasodilation in the isolated working rat heart. Br J Pharmacol. 1999;127:701-708.
12. Burnstock G, Kennedy C. A dual function for adenosine 5′-triphosphate in the regulation of vascular tone: excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res. 1986;58:319-330.
13. Robertson D, Frolich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298:181-186.
14. Pincomb GA, Lovallo WR, Passey RB, Whitsett TL, Silverstein SM, Wilson MF. Effects of caffeine on vascular resistance, cardiac output and myocardial contractility in young men. Am J Cardiol. 1985;56:119-122.
15. Tadamura E, Iida H, Matsumoto K, et al. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. J Am Coll Cardiol. 2001;37:130-136.
16. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 1995;36:78-85.
17. Iida H, Rhodes CG, de Silva R, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 1992;33:1669-1677.
18. Iida H, Kanno I, Takahashi A, et al. Measurement of absolute myocardial blood flow with H2 15O and dynamic positron-emission tomography: strategy for quantification in relation to the partial-volume effect. Circulation. 1988;78:104-115.
19. Campisi R, Nathan L, Pampaloni MH, et al. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation. 2002;105:425-430.
20. Smits P, Straatman C, Pijpers E, Thien T. Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther. 1991;50:529-537.
21. Taillefer R, Amyot R, Turpin S, Lambert R, Pilon C, Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J Nucl Cardiol. 1996;3:204-211.
22. Chan SY, Brunken RC, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 1992;20:979-985.
23. Jeremias A, Filardo SD, Whitbourn RJ, et al. Effects of intravenous and intracoronary adenosine 5′-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation. 2000;101:318-323.
24. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595-1606.
25. Bottcher M, Madsen MM, Refsgaard J, et al. Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve. Circulation. 2001;103:1109-1114.
26. Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert HR. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med. 1995;36:575-580.
27. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492.
28. 2-purinoceptors in the cardiovascular system. Circulation. 1991;84:1-14.
29. Daly JW, Fredholm BB. Caffeine: an atypical drug of dependence. Drug Alcohol Depend. 1998;51:199-206.
30. Statland BE, Demas TJ. Serum caffeine half-lives: healthy subjects vs. patients having alcoholic hepatic disease. Am J Clin Pathol. 1980;73:390-393.
31. Rossen JD, Quillen JE, Lopez AG, Stenberg RG, Talman CL, Winniford MD. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol. 1991;18:485-491.
32. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23:384-389.